Watermark
  Back to Search Results

BGB-A317-A445-201

Active, not recruiting

A Study to Investigate the Antitumor Activity, Safety, Tolerability, and Pharmacokinetics of BGB-A445 in Combination With Tislelizumab in Participants With Select Advanced Solid Tumors.

BeOne Study ID Info icon SVG graphic used for tooltips or additional information.

BGB-A317-A445-201

ClinicalTrials.gov ID Info icon SVG graphic used for tooltips or additional information.

NCT05661955

China Drug Trials ID Info icon SVG graphic used for tooltips or additional information.

CTR20223270

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents

Study Overview

Sex: All Info icon SVG graphic used for tooltips or additional information.

Age: 18 Years / N/A

Accepts Healthy Volunteers? No

No Study Documents